首页> 外文期刊>Molecular and Cellular Biochemistry: An International Journal for Chemical Biology >The changes in beta-adrenoceptor-mediated cardiac function in experimental hypothyroidism: the possible contribution of cardiac beta3-adrenoceptors.
【24h】

The changes in beta-adrenoceptor-mediated cardiac function in experimental hypothyroidism: the possible contribution of cardiac beta3-adrenoceptors.

机译:实验性甲状腺功能减退症中β-肾上腺素受体介导的心脏功能的变化:心脏β3-肾上腺素受体的可能贡献。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Thyroid hormone deficiency has been reported to decrease expression and function of both beta(1)- and beta(2)-adrenoceptor in different tissues including heart. The purpose of this study was to examine the possible contribution of beta(3)-adrenoceptors to cardiac dysfunction in hypothyroidism. In addition, effect of this pathology on beta(1)- and beta(2)-adrenoceptor was investigated. Hypothyroidism was induced by adding methimazole (300 mg/l) to drinking water of rats for 8 weeks. Cardiac hemodynamic parameters were measured in anesthetised rats in vivo. Responses to beta-adrenoceptor agonists were examined in rat papillary muscle in vitro. We also studied the effect of hypotyroidism on mRNA expression of beta-adrenoceptors, Gialpha, GRK, and eNOS in rat heart. All of the hemodynamic parameters (systolic, diastolic and mean arterial pressure, left ventricular pressure, heart rate, +dp/dt, and -dp/dt) were significantly reduced by the methimazole treatment. The negative inotropic effect elicited by BRL 37344 (a beta(3)-adrenoceptor preferential agonist) and positive inotropic effects produced by isoprenaline and noradrenaline, respectively, were significantly decreased in papillary muscle of hypothyroid rats as compared to those of controls. On the other hand, hypothyroidism resulted in increased cardiac beta(2)- and beta(3)-adrenoceptor, Gialpha(2), Gialpha(3), GRK3, and eNOS mRNA expressions. However, beta(1)-adrenoceptor and GRK2 mRNA expressions were not changed significantly in this pathology. These results show that mRNA expression of beta(3)-adrenoceptors as well as the signalling pathway components mediated through beta(3)-adrenoceptors are significantly increased in hypothyroid rat heart. Since we could not correlate these alternates with the decreased negative inotropic response mediated by this receptor subtype, it is not clear whether these changes are important for hypothyroid induced reduction in cardiac function.
机译:据报道,甲状腺激素缺乏会降低包括心脏在内的不同组织中β(1)-和β(2)-肾上腺素受体的表达和功能。这项研究的目的是检查甲状腺功能减退症中β(3)-肾上腺素受体对心脏功能障碍的可能贡献。另外,研究了这种病理学对β(1)-和β(2)-肾上腺素受体的影响。通过在大鼠饮用水中加入甲巯咪唑(300 mg / l)诱导甲状腺功能减退8周。在体内麻醉的大鼠中测量心脏血液动力学参数。在体外大鼠乳头肌中检查对β-肾上腺素受体激动剂的反应。我们还研究了拟甲状腺机能对大鼠心脏中β-肾上腺素受体,Gialpha,GRK和eNOS的mRNA表达的影响。甲巯咪唑治疗可显着降低所有血液动力学参数(收缩压,舒张压和平均动脉压,左心室压,心率,+ dp / dt和-dp / dt)。与对照组相比,甲状腺功能减退大鼠的乳头肌分别由BRL 37344(β(3)-肾上腺素受体优先激动剂)引起的负性肌力作用和异戊萘那林和去甲肾上腺素产生的正性肌力作用明显降低。另一方面,甲状腺功能减退症导致心脏beta(2)-和beta(3)-肾上腺素能受体,Gialpha(2),Gialpha(3),GRK3和eNOS mRNA表达增加。但是,β(1)-肾上腺素受体和GRK2 mRNA表达在这种病理学中没有明显改变。这些结果表明在甲状腺功能低下的大鼠心脏中,β(3)-肾上腺素受体的mRNA表达以及通过β(3)-肾上腺素受体介导的信号传导途径成分显着增加。由于我们无法将这些改变与该受体亚型介导的负性肌力反应降低相关联,因此尚不清楚这些改变是否对甲状腺功能减退引起的心脏功能降低是否重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号